Sinco Pharmaceuticals Holdings Limited (HKG:6833)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1710
-0.0010 (-0.58%)
Jul 31, 2026, 3:32 PM HKT

HKG:6833 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,0852,0852,8212,5402,2722,024
Revenue Growth
-16.29%-26.11%11.07%11.82%12.22%-1.26%
Gross Profit
222.09222.09299.94323.28305.87364.95
Operating Income
74.6874.68113.95116.46101.22192.55
Net Income
34.8534.8542.0542.3569.46135.08
Earnings Per Share
0.020.020.020.020.030.08
EPS Growth
-16.07%-15.00%0%-41.18%-56.28%11.39%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Medical Beauty Services
21.0321.0328.725.9312.19-
Sale of Imported Pharmaceutical Products
2,0642,0642,7932,5142,2592,024
Total
2,0852,0852,8212,5402,2722,024

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
249.2249.2308.32437.92329.14326.05
Total Debt
183.39183.39350.54251.4192.41340.95
Net Cash (Debt)
65.8165.81-42.22186.52136.73-14.9
Net Cash Growth
1292.51%--36.41%--
Net Cash Per Share
0.030.03-0.020.090.07-0.01

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
207.59207.59-232.88353.775.08305.71
Capital Expenditures
-10.03-10.03-35.16-29.55-52.69-23.52
Free Cash Flow
197.55197.55-268.04324.1522.39282.19
Free Cash Flow Growth
---1347.74%-92.07%106.09%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
10.65%10.65%10.63%12.73%13.46%18.03%
Operating Margin
3.58%3.58%4.04%4.58%4.46%9.51%
Pretax Margin
2.32%2.32%3.51%3.93%4.37%8.27%
Profit Margin
1.67%1.67%1.49%1.67%3.06%6.67%
FCF Margin
9.48%9.48%-9.50%12.76%0.99%13.94%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
Dividend Per Share
0.0020.0020.0020.0040.009
Dividend Per Share Growth
-16.50%-20.12%-46.92%-59.16%-
Dividend Yield
0.98%0.95%1.04%1.69%3.96%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
9.049.288.9510.466.8621.21
Forward PE
-15.2815.2815.2815.2815.28
P/FCF Ratio
1.581.64-1.3721.2810.15
PS Ratio
0.150.160.130.170.211.42